{{Rsnum
|rsid=2669858
|Gene=ATP2C1
|Chromosome=3
|position=130946687
|Orientation=minus
|GMAF=0.1387
|Gene_s=ATP2C1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.1 | 23.9 | 69.0
| HCB | 0.0 | 7.5 | 92.5
| JPT | 0.0 | 7.1 | 92.9
| YRI | 4.1 | 31.0 | 64.8
| ASW | 0.0 | 29.1 | 70.9
| CHB | 0.0 | 7.5 | 92.5
| CHD | 0.0 | 12.0 | 88.0
| GIH | 3.0 | 26.7 | 70.3
| LWK | 2.7 | 29.1 | 68.2
| MEX | 5.2 | 12.1 | 82.8
| MKK | 5.1 | 38.5 | 56.4
| TSI | 4.0 | 40.6 | 55.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=22285144
|Title=ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}